Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination
- PMID: 23687580
- PMCID: PMC3656544
- DOI: 10.1093/jpids/pis058
Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination
Abstract
Background: Rotavirus is the most common cause of infectious diarrhea in children worldwide. Recent studies have described changes in the burden of all-cause gastroenteritis; however, there are limited data on the clinical and economic impact of rotavirus vaccine on cases of laboratory-confirmed rotavirus disease.
Methods: We performed a retrospective study of laboratory-confirmed rotavirus disease from July 2003 through June 2010 at a children's hospital and a community hospital in Utah. Demographics and hospital costs for children <5 years with rotavirus symptoms and a positive rotavirus enzyme immunoassay test on a stool specimen were abstracted from electronic medical records. We compared the prevaccine period (2003-2007) with the postvaccine period (2008-2010).
Results: The overall incidence of rotavirus gastroenteritis declined in the postvaccine period, from 26.6 to 5.2 cases per 10 000 person-years for Salt Lake County residents. The largest decrease in the incidence of rotavirus gastroenteritis was among children <12 months (-87%; 95% confidence interval [CI], 79-93). Older children (12-23 months) also experienced significant decreases (-81%; 95% CI, 72-88), as did those 24-59 months (-61%; 95% CI, 51-71). In 2009, 3 years after rotavirus vaccine introduction, there was a 79% decrease in emergency department visits and a 78% decrease in hospitalizations across both hospitals. The cost of emergency department visits and hospitalizations for rotavirus gastroenteritis decreased by 79% and 72%, respectively, resulting in annual savings of $790 000 at a children's hospital and $140 000 at a community hospital.
Conclusion: Rotavirus vaccination in infants has dramatically decreased the clinical burden and direct medical costs of rotavirus gastroenteritis in both infants and young children.
Keywords: Acute Gastroenteritis; Hospital Costs; Immunization; Incidence; Pediatrics.
© The Author 2012. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures



Similar articles
-
Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.Clin Infect Dis. 2016 May 1;62 Suppl 2(Suppl 2):S168-74. doi: 10.1093/cid/civ1210. Clin Infect Dis. 2016. PMID: 27059352 Free PMC article.
-
All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009.Clin Infect Dis. 2012 Aug;55(4):e28-34. doi: 10.1093/cid/cis443. Epub 2012 Apr 27. Clin Infect Dis. 2012. PMID: 22543022
-
Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.Vaccine. 2017 Jan 23;35(4):680-686. doi: 10.1016/j.vaccine.2016.11.057. Epub 2016 Dec 20. Vaccine. 2017. PMID: 28007397 Free PMC article.
-
Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.Pediatr Infect Dis J. 2007 Oct;26(10):914-9. doi: 10.1097/INF.0b013e31812e52fd. Pediatr Infect Dis J. 2007. PMID: 17901797
-
Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data.Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S56-60. doi: 10.1097/INF.0b013e3181fefdc0. Pediatr Infect Dis J. 2011. PMID: 21183842 Review.
Cited by
-
Evaluation of the performance of a multiplex reverse transcription polymerase chain reaction kit as a potential diagnostic and surveillance kit for rotavirus in Kenya.Trop Dis Travel Med Vaccines. 2019 Jul 15;5:12. doi: 10.1186/s40794-019-0087-7. eCollection 2019. Trop Dis Travel Med Vaccines. 2019. PMID: 31346474 Free PMC article.
-
A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impact.Expert Rev Vaccines. 2018 Jul;17(7):593-606. doi: 10.1080/14760584.2018.1489724. Epub 2018 Jul 2. Expert Rev Vaccines. 2018. PMID: 29909693 Free PMC article. Review.
References
-
- Charles MD, Holman RC, Curns AT, Parashar UD, Glass RI, Bresee JS. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J. 2006;25:489–493. - PubMed
-
- Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics. 2008;122:1235–1243. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources